Show results for
Refine by
Genomes Services In Germany
17 services found
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
Whole genome sequencing (WGS) identifies almost all changes in a patient’s DNA by sequencing both the entire protein coding and the non-coding regions of the ...
by:Revvity Gene Delivery (formerly SIRION Biotech) based inHamburg, GERMANY
Revvity Omics is at the forefront of pioneering advancements in healthcare through our sponsored testing programs. Our focus is on both common and rare disorders, and our mission is to empower individuals, promote early diagnosis, and contribute to cutting-edge research that can help transform lives. We take pride in the impact we have made on the lives of countless ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Advances in recombinant DNA technology, genomics and immunology have greatly affected the vaccine development ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
For example, SARS-CoV-2 consists of four structural proteins, including S (spike), E (envelope), M (membrane), and N (nucleocapsid) proteins. S, M and E proteins create the viral envelope together, and N protein holds the SARS-CoV-2 RNA genome. As a key component, spike (S) was identified as the protein responsible for virus entry into human cells. ...
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
Whole Exome Sequencing (WES) is a comprehensive genetic test that identifies changes in a patient's DNA that are causative or related to their medical concerns. By focusing on the entire protein-coding regions of the genome – the exome – WES offers you the coverage you need to diagnose patients rapidly and ...
Manufactured by:NeraCare GmbH based inFrankfurt, GERMANY
Hovever, it is important to remember that no two melanoma patients or their tumors are alike.The MELAGENIX test provides a genomic-based, comprehensive, individualized risk assessment for stage I-III melanoma patients in the adjuvant and neoadjuvant ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
HFrEF occurs when the left ventricular ejection fraction (LVEF) is 40% or less and is accompanied by progressive left ventricular dilatation and adverse cardiac remodelling. Worldwide, the burden of heart failure has increased to an estimated 23 million people, and approximately 50% of cases are HF-rEF. Despite several therapeutic options, heart failure with reduced ejection fraction remains a ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
Kearns-Sayre Syndrome (KSS) is a mitochondrial disease, with Rare Disease designation (7,400 – 22,000 patients in Europe), caused primarily by large-scale mitochondrial DNA deletions. Cardiac dysfunction is the principal clinical manifestation and primary cause of death. There are no current treatment options available that go beyond addressing some of the symptoms associated with KSS thus ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
Loss of cardiomyocytes (heart cells) is the primary hallmark of heart failure. However, unlike other cell types, there is a limited capacity for cardiomyocytes proliferation in the adult heart and in the failing human heart. Therefore, regenerative approaches to replenish the lost cardiomyocytes are necessary to recover the contractile capacity of the heart and prevent death. Targeting ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
Cardiotoxicity is a growing issue in Oncology: cardio-oncology is an emerging discipline focused predominantly on the detection and management of cancer treatment-induced cardiac dysfunction (cardiotoxicity). Around 20% of all cancer survivors will develop cardiovascular co-morbidities, with 1 in 10 cancer patients dying from cardiovascular complication, rather than cancer. In 2016, the European ...
Manufactured by:ARTES Biotechnology GmbH based inLangenfeld, GERMANY
The focus of our tailor-made offer is on microbial production cell lines based on yeast (Hansenula, Pichia and Saccharomyces) and bacteria (E. coli). To meet customer’s demand, ARTES Biotechnology develops the most efficient solution for the target of choice. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs provides excellent services for the construction and screening of immune antibody library generated by our advanced phage display technology. Our professional scientists can generate antibody libraries from diverse species, including common laboratory animals [e.g. rodents, rabbit, chicken, dog and monkey (NHP)], and some infrequent antibody sources such as human, camel, shark, ...
by:Indivumed GmbH based inHamburg, GERMANY
IndivuType uses our highest quality biospecimens and clinical data, combined with leading-edge analytical methods, to offer a unique multi-omics database. Thus, providing new insights into the biology of cancer and enabling new discoveries in the postgenomic ...
by:Indivumed GmbH based inHamburg, GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
by:Indivumed GmbH based inHamburg, GERMANY
Cancer immunology, or “immuno-oncology,” is a growing field of research that aims to discover innovative cancer immunotherapies to treat and impede the progression of the disease. Understanding how cancer evades the immune system is the basis of immuno-oncology. With Indivumed’s scientific support you can, for example, identify the different types of immune cells and their ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs has been a long-term expert and market leader in the field of phage display and antibody engineering. Through our unparalleled phage display platform, Creative Biolabs offers integrated service of cDNA library construction to our customers over the ...
by:PharmaLex GMBH based inFriedrichsdorf, GERMANY
The Global Statistics and Data Science (GSDS) team at PharmaLex delivers analytical support for the development of medical products–from early research through pre-clinical to late phase studies, plus manufacturing and health economics. We support our clients every step of the way–from discovery and non-clinical requirements to early strategic planning, clinical development, CMC ...